Introduction {#Sec1}
============

The polyamine, putrescine, was first isolated from putrefying meat but is thought to play an important role in cell growth and differentiation (\[[@CR1]\]). It also generates succinate via GABA and can thus serve as an energy source to the small intestine (\[[@CR2]\]). Elevated plasma putrescine levels have been reported in an endotoxic rodent model (\[[@CR3]\]). We have previously characterized a 72 h fluid-resuscitated rat model of faecal peritonitis where prognostication can be accurately made as early as 6 h post-insult (\[[@CR4]\]).

Objectives {#Sec2}
==========

Using this long-term sepsis model, to assess differences in liver and plasma levels of putrescine in predicted survivors and non-survivors.

Methods {#Sec3}
=======

Awake, instrumented yet fully mobile male Wistar rats (325 ± 15 g) received an i.p. injection of 4µl/g faecal slurry. Fluid resuscitation (50:50 mix of 5% glucose/Hartmann\'s; 10 ml/kg/h) was commenced at 2 h. At 6 h, an echo-measured heart rate cut-off of 460 bpm was used to classify animals into predicted survivors or non-survivors. Animals were sacrificed at 6 h, 24 h or 72 h for liver and blood sampling. A group of control animals were treated identically but without injection of faecal slurry. Putrescine levels were measured using mass spectrometry. Results were analysed using two-way ANOVA and post-hoc testing and considered statistically significant when p \< 0.05.

Results {#Sec4}
=======

In this model septic animals had a mortality rate of 56% with death occurring between 18-36 h. At 6 h septic animals displayed only mild clinical features of illness. However, even as early as 6 h, significant differences were noted in putrescine levels in liver and plasma from non-surviving septic animals.

Conclusions {#Sec5}
===========

An association was seen between eventual non-survival and elevated putrescine levels in both liver and plasma at both 6 h and 24 h. The significance of this finding warrants further investigation.Table 1Putrescine level (µmol/L)ControlSeptic SurvivorsSeptic Non-Survivors6 hPlasma1.59 ± 0.201.91 ± 0.243.51 ± 0.42\*Liver0.29 ± 0.060.41 ± 0.133.58 ± 0.63\*24 hPlasma1.39 ± 0.101.68 ± 0.174.20 ± 0.82\*Liver0.44 ± 0.210.42 ± 0.163.61 ± 1.45\*72 hPlasma1.28 ± 0.091.20 ± 0.12-Liver0.47 ± 0.100.31 ± 0.09-***Data shown as median ± SE; \* p \< 0.05***

Grant Acknowledgement {#Sec6}
=====================

ESICM Basic Science Award, Intensive Care Foundation (UK), NIHR
